Not too much to note here, Q3 running within expectations. EBITDA margins in-line with guidance so far and more billable staff being added. Looks good. Banked the divvy and now back to sleep until the FY result I think.
RXP Price at posting:
58.0¢ Sentiment: Buy Disclosure: Held
